|
Neurological deficits and functional impairment
|
|
NIHSS
|
National Institute of Health stroke scale [26]
|
Baseline, months 3, 6, 9 and 12
|
|
mRS
|
modified Rankin scale [27]
|
Baseline, months 3, 6, 9 and 12
|
|
BI
|
Barthel index [28]
|
Baseline, months 3, 6, 9 and 12
|
|
Depression and anxiety symptoms
|
|
PHQ-9
|
Patient health questionnaire 9 items [29]
|
Every month
|
|
HADS
|
Hospital anxiety and depression scale [30]
|
Baseline, months 3, 6, 9 and 12
|
|
Quality of life
|
|
EQ-5D
|
EuroQoL 5 dimensions [31]
|
Every month
|
|
SF-36
|
Short form (36) health survey [32]
|
Baseline, months 3, 6, 9 and 12
|
|
Adherence
|
|
AAQ
|
Adherence assessment questionnaire [33]
|
Baseline, months 6 and 12
|
|
ABQ
|
Adherence barriers questionnaire [34]
|
Baseline, months 6 and 12
|
|
Empowerment
|
|
HCEI
|
Healthcare empowerment inventory [35]
|
Baseline, months 3, 6, 9 and 12
|
|
Neuropsychological and cognitive impairment
|
|
BT
|
Bells test [36]
|
Irregular
|
|
TMT
|
Trail making test [37]
|
Irregular
|
|
MMSE
|
Mini mental status examination [38]
|
Baseline, months 3, 6, 9 and 12
|
